EMN
55
5
CA
25
3
NWS
79
-4
KMX
61
3
AKAM
47
5
MAS
60
-2
GT
64
-3
HSY
35
3
NTRS
59
2
ZBH
62
3
EQT
59
5
AAPL
40
-5
XOM
48
-2
BIIB
30
-9
PSA
58
-2
COST
63
-4
KSS
46
7
WFC
82
7
WYNN
30
2
VMC
62
-3
EMN
55
5
CA
25
3
NWS
79
-4
KMX
61
3
AKAM
47
5
MAS
60
-2
GT
64
-3
HSY
35
3
NTRS
59
2
ZBH
62
3
EQT
59
5
AAPL
40
-5
XOM
48
-2
BIIB
30
-9
PSA
58
-2
COST
63
-4
KSS
46
7
WFC
82
7
WYNN
30
2
VMC
62
-3
Financhill
Back

Kymera Therapeutics Stock Predictions

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
78

KYMR
Kymera Therapeutics

Last Price:
50.04
Seasonality Move:
52.76%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 46.1% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $51.83. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 46.1% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
78
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
13.96

Prediction Charts

Market Cap:
3.36B
Price in USD:
51.83
Volume:
392.41K
Beta:
2.19

Technical Analysis

SMA50:
47.17
SMA100:
43.98
SMA200:
40.35
52-Wk Change:
256.96%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 51.83 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 48.25 48.76 49.33 47.50
Oct-24 48.95 48.73 49.79 48.37
Oct-25 49.03 47.99 49.53 47.07
Oct-28 49.01 49.08 50.29 48.84
Oct-29 48.53 48.49 49.16 47.75
Oct-30 48.12 47.65 48.57 47.26
Oct-31 44.75 46.20 46.98 42.62
Nov-1 47.10 46.47 47.65 45.20
Nov-4 46.10 47.07 47.93 45.16
Nov-5 46.98 47.69 48.88 46.35
Nov-6 49.93 49.52 51.14 48.47
Nov-7 49.52 49.86 50.99 48.58
Nov-8 49.91 50.94 51.13 49.39
Nov-11 51.97 51.83 53.23 51.45

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.